Filana Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +17.6% | -26.0% | -17.3% | |
| – | +122.0% | +255.2% | +20.2% | |
| – | – | -120.1% | – | |
| – | -84.7% | -75.1% | +464.1% | |
| – | – | – | – | |
| – | -94.6% | +4,762.1% | -100.2% | |
| – | – | – | -544.6% | |
| – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.